Valeant sales up 34% for Q4; Richter gets European nod for fibroid drug;

@FiercePharma: Glenmark pulls 7 lots of contraceptive pills on a packaging error that could cause incorrect dosing/pregnancy risk. Article | Follow @FiercePharma

> Valeant Pharmaceuticals ($VRX) posted fourth-quarter profits, aided by growth in its dermatology business and added sales from newly acquired companies. Report

> Gedeon Richter, Hungary's largest drugmaker, said its Esmya drug won European regulatory approval for pre-operative treatment of uterine fibroids, an indication expected to net $134 million in peak sales. News

> Novartis ($NVS) said its cancer drug Glivec won European approval for three years of treatment after surgery in patients with certain gastrointestinal tumors. Release

> Access Pharmaceuticals said MuGard, its oral mucositis drug, won marketing approval in China, where it will be sold by partner Rhei Pharmaceuticals. Item

> Ear treatment specialist Otic Pharma raised $4.3 million from Orbimed to develop foam-based treatments for people and dogs. Article

Biotech News

@FierceBiotech: Brain switch turns 'on' when danger hits, 'off' when threat passes. Item | Follow @FierceBiotech

@JohnCFierce: MDV3100 release this a.m. includes new survey on specialists, desire for new prostate cancer drugs. Release | Follow @JohnCFierce

@RyanMFierce: Help me find the world's smartest biotech techies for new Fierce special report: Report | Follow @RyanMFierce

@FierceMedDev: AngioDynamics' new chief playing offense and ready for risk. Via @Business_Review. Article | Follow @FierceMedDev

> Study finds no (unique) industry bias in published trial results. Report

> GSK lassos rare disease program in Angiochem tie-up. Story

> FDA rejects Columbia Labs' gel to prevent preterm births. News

Medical Devices News

> Autonomic tackles migraines with neurostimulation tech. Article

> InSightec scores $13.75M from GE. Story

> Wright sees quarterly sales, net income drop. News

> Can U.S. ensure access to a 2nd diagnostic test? Item

IT News

> Roche getting entire workforce to use Google Apps. Story

> Startup aims to tap wisdom of the crowd for low-cost drug trials. Article

> J&J hires Selventa to build computerized models for personalized medicine. News

And Finally... Scientists have identified a key suspect in metabolic syndrome, which increases risks of diabetes and heart disease. Report